Meadow Creek Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$1.05M Buy
11,594
+286
+3% +$25.8K 0.02% 479
2019
Q2
$955K Buy
11,308
+6,644
+142% +$561K 0.02% 503
2019
Q1
$411K Buy
4,664
+1,100
+31% +$96.9K 0.01% 760
2018
Q4
$254K Buy
+3,564
New +$254K 0.01% 881